Fisher & Paykel Healthcare Corporation Limited (FPH) is currently Overvalued by 77.05%

Instant valuation answer

Fisher & Paykel Healthcare Corporation Limited (FPH) appears overvalued by approximately 77.05% based on our live valuation percent and intrinsic value estimate derived from DCF, P/E Multiple, and P/S Multiple models. Valuation can still differ across analyst models, growth expectations, and risk assumptions.

  • Downside (live) 77.05% (from live valuation API)
  • Confidence (live) 8.5/10 (High conviction overvalued)

Confidence Score is based on the magnitude of upside or downside vs intrinsic value.

Fair value estimate

Unlock fair value

Current price

$36.31

Explore Our Valuation Calculators

Why is Fisher & Paykel Healthcare Corporation Limited overvalued or undervalued?

For Fisher & Paykel Healthcare Corporation Limited, intrinsic value ties fair value to sustainable cash generation; with the stock above that level, the snapshot reads as a premium versus fundamentals rather than a pure sentiment call.

Historical valuation for FPH shows cycles where multiples expanded and compressed; today’s positioning rhymes more with growth optimism than the mid-range of its recent history.

Market expectations boil down to growth, risk, and return on capital—current levels bake in strong execution, so disappointments hit harder. Cross-check with live ratios when your API is connected.

Key metrics

P/E ratio
49.8x
Revenue growth (TTM y/y)
4%
Profit margin
10.2%
Fair value (model)
Unlock

Frequently asked questions — FPH

Is FPH overvalued right now?

Based on our 2026 models, Fisher & Paykel Healthcare Corporation Limited (FPH) appears overvalued at $36.31 with roughly 77.1% downside versus fair value. Confirm with valuation ratios and financials before acting.

What is Fisher & Paykel Healthcare Corporation Limited's intrinsic value?

Our DCF, P/E Multiple, and P/S Multiple models estimate whether FPH trades above or below fair value. At $36.31, Fisher & Paykel Healthcare Corporation Limited currently looks overvalued on this snapshot. Tickerplace Pro unlocks the full dollar fair value estimate.

How is Fisher & Paykel Healthcare Corporation Limited's intrinsic value calculated?

Tickerplace calculates FPH's fair value using Discounted Cash Flow (DCF), P/E Multiple, and P/S Multiple models. We compare the resulting intrinsic value estimate to the live market price to flag undervalued or overvalued positioning.

Is FPH undervalued right now?

A stock is undervalued when price sits below a supportable fair value range. Check whether FPH's gap aligns with fundamentals using the ratios and financial links on this page.